Sam Houston state developing lab test for bath salts

Sam Houston State University is developing a laboratory test to detect the use of bath salts, a new designer drug that was added to the list of illegal substances by the Drug Enforcement Administration in 2011.

Sam Houston State University received a federal grant from the National Institute of Justice to create a test for key components of in in crime labs.

Bath salts, also known as synthetic cathinones, were legally sold in convenience stores, head shops and on the Internet until being included on the list of through an emergency order by the Enforcement Administration in October 2011. These drugs, that are capable of producing powerful hallucinogenic and adrenergic effects, are routinely seized in drug cases around the Houston metropolitan area and throughout the nation.

"Bath salts are the new breed of designer amphetamines, and they pose a number of challenges for from a public safety and public health standpoint," said Sarah Kerrigan, Director of the Forensic Science Program at Sam Houston State University.

According to the , bath salts also have adverse effects including rapid which may lead to heart attacks and strokes, chest pains, nosebleeds, sweating, nausea, and vomiting. Those who abuse the substance also report agitation, insomnia, irritability, dizziness, depression, paranoia, delusions, suicidal thoughts, seizures, and panic attacks.

According to a 2011 report from the National Drug Intelligence Center, drug users are attracted to bath salts because they can evade most drug tests and, as a result, it may not be detected in impaired driving cases or death investigations.

"Analytical limitations for state and local forensic toxicology laboratories impact criminal and death investigation casework, and these deficiencies can have serious criminal justice consequences," Kerrigan said.

While bath salts are easy to detect in seized samples, such as pills, powders and capsules, once they are ingested, they pose a number of challenges in the toxicology lab. The Department of Forensic Science will develop a procedure to detect at least eight of the most common components found in bath salts in biological evidence. These components include mephedrone, flephedrone, methylone , butylone, ethylone, methedrone, MDPV, and naphyrone.

Many toxicology labs use gas chromatography-mass spectrometry (GC/MS) to identify drugs in biological evidence. The new study will target a wide variety of the new designer drugs using one procedure.

add to favorites email to friend print save as pdf

Related Stories

Researchers tackle designer drug craze

Jul 16, 2012

(Medical Xpress) -- President Obama signed a bill into law this week designating certain chemicals found in designer drugs as FDA-controlled substances.

Bath salts emerging as new recreational drugs

Oct 24, 2011

The use of bath salts as recreational drugs has greatly escalated in recent years. Researchers from the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma describe an incident of a man experiencing significant ...

White House warns of 'bath salt' stimulants

Feb 02, 2011

President Barack Obama's drug czar warned Americans Tuesday about the growing threat of designer drugs marketed as "bath salts" that are in fact dangerous amphetamine-type stimulants.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments